Ledipasvir plus sofosbuvir: Hint of added benefit in further patient group

(Institute for Quality and Efficiency in Health Care) The documents subsequently submitted by the manufacturer show an advantage in sustained virologic response also for hepatitis C infection of genotype 1 with HIV coinfection without cirrhosis of the liver.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news